Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 24 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 22 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (2)
Early P 1 (1)
P 1 (20)

Trial Status

Completed22
Not Yet Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07396844Phase 1Not Yet Recruiting

The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers

NCT05995119Early Phase 1Completed

Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers

NCT05837572Not ApplicableUnknown

Development of the Leeds Food Preference Questionnaire in Spanish

NCT03390881Not ApplicableCompleted

Use of Breath Acetone aa a Marker of Energy Balance

NCT01721187Completed

Satiety Effects on the Neural Valuation of Food

NCT01884909Phase 1CompletedPrimary

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions

NCT01827878Phase 1CompletedPrimary

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

NCT01744873Phase 1CompletedPrimary

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition

NCT01567501Phase 1CompletedPrimary

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

NCT01735344Phase 1CompletedPrimary

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

NCT01735383Phase 1CompletedPrimary

Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition

NCT01722110Phase 1CompletedPrimary

Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition

NCT01603186Phase 1CompletedPrimary

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition

NCT01618760Phase 1CompletedPrimary

Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition

NCT01618825Phase 1CompletedPrimary

Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition

NCT01578265Phase 1CompletedPrimary

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition

NCT01505998Phase 1CompletedPrimary

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

NCT01503424Phase 1CompletedPrimary

Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study

NCT01503450Phase 1CompletedPrimary

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition

NCT01372306Phase 1CompletedPrimary

Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition

Scroll to load more

Research Network

Activity Timeline